What is Arteris, Inc.'s earnings per share (EPS)?

Arteris, Inc. (AIP) reported diluted earnings per share of $-0.82 for fiscal year 2025. This represents a 4.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Arteris, Inc. Financials

AIP

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Arteris, Inc. (AIP) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AIP FY2025 2026-04-22

Arteris is still running a research-heavy model, but working-capital improvement let FY2025 cash generation outrun its losses.

FY2025 revenue grew 22.3% while receivables fell, helping operating cash flow turn positive even with an operating margin of -46.9%. That swing suggests the cash improvement came more from collection timing and working-capital release than from a fully repaired cost structure.

The striking combination is a 90.2% gross margin and a -46.9% operating margin: delivering the product is inexpensive, but development and go-to-market spending still absorb more than the gross profit can support. In other words, this is an expense-structure problem more than a unit-economics problem, and current growth has not yet produced meaningful fixed-cost absorption.

Short-term liquidity improved as cash rose to $33.9M and free cash flow turned positive at $5.3M in FY2025. But negative equity remains: liabilities exceeded assets by about $14.6M, and the current ratio was only 1.1x, leaving less balance-sheet cushion than the cash rebound alone suggests.

Financial Health Signals

Financial Profile 15/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Arteris, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Arteris, Inc. has an operating margin of -46.9%, meaning the company retains $-47 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -54.7% the prior year.

Growth

Arteris, Inc.'s revenue surged 22.3% year-over-year to $70.6M, reflecting rapid business expansion. This strong growth earns a score of 58/100.

Leverage

Arteris, Inc. has elevated debt relative to equity (D/E of -8.86), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Liquidity

Arteris, Inc.'s current ratio of 1.13 is below the typical benchmark, resulting in a score of 18/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Arteris, Inc.'s free cash flow margin of 7.6% results in a low score of 17/100. Capital expenditures of $1.4M absorb a large share of operating cash flow.

Piotroski F-Score Neutral

5/9

Arteris, Inc. passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Mixed

-0.19x

For every $1 of reported earnings, Arteris, Inc. generates $-0.19 in operating cash flow ($6.7M OCF vs -$34.7M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk

-171.7x

Arteris, Inc. earns $-171.7 in operating income for every $1 of interest expense (-$33.1M vs $193K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$70.6M

YoY+22.3%

5Y CAGR+17.3%

Arteris, Inc. generated $70.6M in revenue in fiscal year 2025. This represents an increase of 22.3% from the prior year.

EBITDA

-$29.8M

YoY-5.4%

Arteris, Inc.'s EBITDA was -$29.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 5.4% from the prior year.

Net Income

-$34.7M

YoY-3.3%

Arteris, Inc. reported -$34.7M in net income in fiscal year 2025. This represents a decrease of 3.3% from the prior year.

EPS (Diluted)

$-0.82

YoY+4.7%

Arteris, Inc. earned $-0.82 per diluted share (EPS) in fiscal year 2025. This represents an increase of 4.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$5.3M

YoY+612.0%

5Y CAGR+28.8%

Arteris, Inc. generated $5.3M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 612.0% from the prior year.

Cash & Debt

$33.9M

YoY+147.7%

5Y CAGR+23.6%

Arteris, Inc. held $33.9M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

45M

YoY+11.0%

5Y CAGR+19.7%

Arteris, Inc. had 45M shares outstanding in fiscal year 2025. This represents an increase of 11.0% from the prior year.

Margins & Returns

Gross Margin

90.2%

YoY+0.6pp

5Y CAGR-5.1pp

Arteris, Inc.'s gross margin was 90.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.6 percentage points from the prior year.

Operating Margin

-46.9%

YoY+7.8pp

5Y CAGR-35.1pp

Arteris, Inc.'s operating margin was -46.9% in fiscal year 2025, reflecting core business profitability. This is up 7.8 percentage points from the prior year.

Net Margin

-49.2%

YoY+9.0pp

5Y CAGR-39.0pp

Arteris, Inc.'s net profit margin was -49.2% in fiscal year 2025, showing the share of revenue converted to profit. This is up 9.0 percentage points from the prior year.

Return on Equity

N/A

Capital Allocation

R&D Spending

$49.9M

YoY+10.9%

5Y CAGR+24.0%

Arteris, Inc. invested $49.9M in research and development in fiscal year 2025. This represents an increase of 10.9% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$1.4M

YoY+328.4%

5Y CAGR+16.2%

Arteris, Inc. invested $1.4M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 328.4% from the prior year.

AIP Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$70.6M+22.3%	$57.7M+7.6%	$53.7M+6.5%	$50.4M+33.0%	$37.9M+19.0%	$31.8M
Cost of Revenue	$6.9M+15.6%	$6.0M+17.4%	$5.1M+18.6%	$4.3M+14.7%	$3.7M+150.2%	$1.5M
Gross Profit	$63.7M+23.0%	$51.8M+6.5%	$48.6M+5.4%	$46.1M+35.1%	$34.1M+12.6%	$30.3M
R&D Expenses	$49.9M+10.9%	$45.0M-0.3%	$45.1M+9.6%	$41.2M+33.6%	$30.8M+81.0%	$17.0M
SG&A Expenses	$20.1M+14.7%	$17.6M-2.2%	$17.9M+9.6%	$16.4M+22.5%	$13.4M+82.3%	$7.3M
Operating Income	-$33.1M-4.9%	-$31.6M+10.1%	-$35.1M-21.8%	-$28.9M-32.6%	-$21.8M-476.3%	-$3.8M
Interest Expense	$193K-3.5%	$200K-5.2%	$211K+137.1%	$89K-15.2%	$105K+5.0%	$100K
Income Tax	$1.5M-41.0%	$2.5M+49.1%	$1.7M+502.2%	-$417K-140.1%	$1.0M+1.4%	$1.0M
Net Income	-$34.7M-3.3%	-$33.6M+8.8%	-$36.9M-34.6%	-$27.4M-17.1%	-$23.4M-617.3%	-$3.3M
EPS (Diluted)	$-0.82+4.7%	$-0.86+16.5%	$-1.03-22.6%	$-0.84+20.8%	$-1.06-457.9%	$-0.19

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$22.9M+13.9%	$20.1M+15.7%	$17.4M+5.5%	$16.5M-0.2%	$16.5M+6.7%	$15.5M+5.3%	$14.7M+0.9%	$14.6M
Cost of Revenue	$3.3M+74.6%	$1.9M+5.4%	$1.8M+1.4%	$1.7M+14.2%	$1.5M-3.1%	$1.6M+7.8%	$1.5M+0.2%	$1.5M
Gross Profit	$19.7M+7.7%	$18.3M+16.8%	$15.6M+6.0%	$14.8M-1.6%	$15.0M+7.8%	$13.9M+5.0%	$13.3M+1.0%	$13.1M
R&D Expenses	$14.5M+9.3%	$13.2M+4.6%	$12.6M+3.9%	$12.2M+2.6%	$11.9M+2.9%	$11.5M-3.3%	$11.9M+11.3%	$10.7M
SG&A Expenses	$5.4M-16.0%	$6.4M+32.7%	$4.9M+7.9%	$4.5M+4.1%	$4.3M+5.0%	$4.1M-3.9%	$4.3M-11.2%	$4.8M
Operating Income	-$9.3M-9.8%	-$8.5M+2.8%	-$8.7M-5.6%	-$8.2M-7.0%	-$7.7M-8.5%	-$7.1M+10.3%	-$7.9M-6.4%	-$7.4M
Interest Expense	$38K+167.9%	-$56K-214.3%	$49K-51.0%	$100K0.0%	$100K+231.6%	-$76K-176.0%	$100K0.0%	$100K
Income Tax	-$3.7M-19363.2%	-$19K-105.0%	$380K-55.1%	$846K+215.7%	$268K-78.5%	$1.2M+1455.4%	-$92K-109.4%	$975K
Net Income	-$8.0M+6.4%	-$8.5M+5.4%	-$9.0M+1.5%	-$9.1M-12.4%	-$8.1M+1.0%	-$8.2M-6.7%	-$7.7M+7.9%	-$8.3M
EPS (Diluted)	$-0.17	N/A	$-0.21+4.5%	$-0.22-10.0%	$-0.20	N/A	$-0.20+9.1%	$-0.22

AIP Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$115.0M+8.4%	$106.1M+3.2%	$102.8M-11.0%	$115.5M-4.1%	$120.4M+181.8%	$42.7M
Current Assets	$82.4M+19.3%	$69.1M+18.2%	$58.4M-28.0%	$81.1M-23.9%	$106.6M+268.4%	$29.0M
Cash & Equivalents	$33.9M+147.7%	$13.7M-0.1%	$13.7M-63.4%	$37.4M-56.4%	$85.8M+630.8%	$11.7M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$19.2M-6.9%	$20.6M+71.7%	$12.0M+68.0%	$7.1M-48.5%	$13.9M-3.3%	$14.3M
Goodwill	$4.2M0.0%	$4.2M0.0%	$4.2M-0.9%	$4.2M+57.6%	$2.7M0.0%	$2.7M
Total Liabilities	$129.7M+20.8%	$107.3M+22.4%	$87.7M+12.5%	$78.0M+15.5%	$67.5M+37.7%	$49.0M
Current Liabilities	$73.2M+23.5%	$59.3M+27.8%	$46.4M+6.3%	$43.7M+2.8%	$42.5M+50.5%	$28.2M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$14.6M-1131.6%	-$1.2M-107.9%	$15.1M-59.8%	$37.5M-29.1%	$52.9M+540.6%	-$12.0M
Retained Earnings	-$171.6M-25.4%	-$136.9M-32.6%	-$103.2M-55.5%	-$66.4M-70.2%	-$39.0M-149.8%	-$15.6M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$139.9M+21.6%	$115.0M+6.8%	$107.7M+0.8%	$106.9M+8.7%	$98.3M-7.4%	$106.1M+8.6%	$97.7M+1.4%	$96.4M
Current Assets	$61.5M-25.3%	$82.4M+35.0%	$61.0M-0.8%	$61.5M+7.2%	$57.4M-16.9%	$69.1M+10.0%	$62.8M+6.6%	$58.9M
Cash & Equivalents	$11.7M-65.6%	$33.9M+94.6%	$17.4M+8.2%	$16.1M-1.7%	$16.4M+19.6%	$13.7M-23.2%	$17.8M-19.4%	$22.1M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$14.7M-23.4%	$19.2M+16.4%	$16.5M-12.1%	$18.8M+82.6%	$10.3M-50.2%	$20.6M+136.5%	$8.7M-2.6%	$8.9M
Goodwill	$35.2M+742.4%	$4.2M0.0%	$4.2M0.0%	$4.2M0.0%	$4.2M0.0%	$4.2M0.0%	$4.2M0.0%	$4.2M
Total Liabilities	$137.3M+5.9%	$129.7M+8.8%	$119.2M+4.2%	$114.4M+10.9%	$103.1M-3.9%	$107.3M+12.4%	$95.5M+4.8%	$91.1M
Current Liabilities	$84.5M+15.5%	$73.2M+9.6%	$66.8M+6.7%	$62.6M+10.6%	$56.5M-4.6%	$59.3M+9.3%	$54.2M+4.8%	$51.7M
Long-Term Debt	$452K	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$2.6M+117.7%	-$14.6M-27.8%	-$11.4M-52.1%	-$7.5M-56.2%	-$4.8M-305.8%	-$1.2M-153.8%	$2.2M-58.1%	$5.3M
Retained Earnings	-$179.6M-4.6%	-$171.6M-5.2%	-$163.1M-5.8%	-$154.1M-6.3%	-$145.0M-5.9%	-$136.9M-6.4%	-$128.7M-6.4%	-$121.0M

AIP Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$6.7M+1035.1%	-$720K+95.4%	-$15.7M-132.4%	-$6.8M-731.3%	-$814K-137.6%	$2.2M
Capital Expenditures	$1.4M+328.4%	$324K-78.4%	$1.5M+43.0%	$1.1M+30.1%	$808K+23.5%	$654K
Free Cash Flow	$5.3M+612.0%	-$1.0M+93.9%	-$17.2M-120.4%	-$7.8M-382.0%	-$1.6M-207.5%	$1.5M
Investing Cash Flow	$12.0M+1140.0%	$970K+120.7%	-$4.7M+87.5%	-$37.5M-2658.0%	-$1.4M+73.6%	-$5.1M
Financing Cash Flow	$1.4M+640.8%	-$262K+91.0%	-$2.9M+29.7%	-$4.2M-105.4%	$76.3M+9552.4%	$790K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$7.1M-322.8%	$3.2M-0.6%	$3.2M+228.3%	-$2.5M-186.9%	$2.9M+208.7%	-$2.6M-334.3%	$1.1M+261.1%	$311K
Capital Expenditures	$295K+120.1%	$134K-81.3%	$716K+101.7%	$355K+94.0%	$183K+266.0%	$50K+61.3%	$31K-34.0%	$47K
Free Cash Flow	-$7.4M-342.3%	$3.0M+22.8%	$2.5M+187.0%	-$2.8M-206.1%	$2.7M+199.9%	-$2.7M-345.5%	$1.1M+313.6%	$264K
Investing Cash Flow	-$16.0M-222.7%	$13.1M+901.7%	-$1.6M-331.3%	$705K+682.6%	-$121K+93.7%	-$1.9M+58.5%	-$4.6M-6.7%	-$4.4M
Financing Cash Flow	$882K+521.1%	$142K+178.5%	-$181K-112.0%	$1.5M+3000.0%	-$52K-112.6%	$414K+153.4%	-$775K-1509.1%	$55K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

AIP Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	90.2%+0.6pp	89.7%-0.9pp	90.5%-1.0pp	91.5%+1.4pp	90.1%-5.2pp	95.3%
Operating Margin	-46.9%+7.8pp	-54.7%+10.7pp	-65.5%-8.2pp	-57.3%+0.2pp	-57.5%-45.6pp	-11.9%
Net Margin	-49.2%+9.0pp	-58.3%+10.4pp	-68.7%-14.3pp	-54.4%+7.4pp	-61.8%-51.5pp	-10.3%
Return on Equity	N/A	N/A	-244.1%-171.2pp	-73.0%-28.8pp	-44.2%	N/A
Return on Assets	-30.2%+1.5pp	-31.7%+4.2pp	-35.9%-12.1pp	-23.7%-4.3pp	-19.4%-11.8pp	-7.6%
Current Ratio	1.13-0.0	1.17-0.1	1.26-0.6	1.86-0.7	2.51+1.5	1.03
Debt-to-Equity	-8.86+81.5	-90.34-96.1	5.81+3.7	2.08+0.8	1.28+5.4	-4.08
FCF Margin	7.6%+9.4pp	-1.8%+30.3pp	-32.1%-16.6pp	-15.5%-11.2pp	-4.3%-9.0pp	4.7%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	85.8%-4.9pp	90.8%+0.9pp	89.9%+0.4pp	89.4%-1.3pp	90.8%+0.9pp	89.8%-0.2pp	90.1%+0.1pp	90.0%
Operating Margin	-40.6%+1.5pp	-42.0%+8.0pp	-50.1%-0.1pp	-50.0%-3.4pp	-46.6%-0.8pp	-45.9%+8.0pp	-53.8%-2.8pp	-51.0%
Net Margin	-34.7%+7.5pp	-42.2%+9.4pp	-51.6%+3.7pp	-55.3%-6.2pp	-49.1%+3.8pp	-53.0%-0.7pp	-52.3%+5.0pp	-57.3%
Return on Equity	-307.2%	N/A	N/A	N/A	N/A	N/A	-348.0%-189.8pp	-158.2%
Return on Assets	-5.7%+1.7pp	-7.4%+1.0pp	-8.3%+0.2pp	-8.5%-0.3pp	-8.3%-0.5pp	-7.7%+0.1pp	-7.9%+0.8pp	-8.7%
Current Ratio	0.73-0.4	1.13+0.2	0.91-0.1	0.98-0.0	1.02-0.1	1.170.0	1.16+0.0	1.14
Debt-to-Equity	52.99+61.8	-8.86+1.5	-10.41+4.8	-15.20+6.2	-21.39+68.9	-90.34-133.6	43.23+26.0	17.27
FCF Margin	-32.1%-47.2pp	15.1%+0.9pp	14.2%+31.4pp	-17.2%-33.4pp	16.2%+33.5pp	-17.3%-24.7pp	7.4%+5.6pp	1.8%

Note: Shareholder equity is negative (-$14.6M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Sealsq Corp LAES

$621.5M

Poet Technologies Inc POET

$2.2B

Nve Corp NVEC

$406.9M

Ceva Inc CEVA

$1.0B

Skywater Technology Inc SKYT

$1.7B

Frequently Asked Questions

What is Arteris, Inc.'s annual revenue?

Arteris, Inc. (AIP) reported $70.6M in total revenue for fiscal year 2025. This represents a 22.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Arteris, Inc.'s revenue growing?

Arteris, Inc. (AIP) revenue grew by 22.3% year-over-year, from $57.7M to $70.6M in fiscal year 2025.

Is Arteris, Inc. profitable?

No, Arteris, Inc. (AIP) reported a net income of -$34.7M in fiscal year 2025, with a net profit margin of -49.2%.

What is Arteris, Inc.'s EBITDA?

Arteris, Inc. (AIP) had EBITDA of -$29.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Arteris, Inc.'s gross margin?

Arteris, Inc. (AIP) had a gross margin of 90.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Arteris, Inc.'s operating margin?

Arteris, Inc. (AIP) had an operating margin of -46.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Arteris, Inc.'s net profit margin?

Arteris, Inc. (AIP) had a net profit margin of -49.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Arteris, Inc.'s free cash flow?

Arteris, Inc. (AIP) generated $5.3M in free cash flow during fiscal year 2025. This represents a 612.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Arteris, Inc.'s operating cash flow?

Arteris, Inc. (AIP) generated $6.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Arteris, Inc.'s total assets?

Arteris, Inc. (AIP) had $115.0M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Arteris, Inc.'s capital expenditures?

Arteris, Inc. (AIP) invested $1.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Arteris, Inc. spend on research and development?

Arteris, Inc. (AIP) invested $49.9M in research and development during fiscal year 2025.

How many shares does Arteris, Inc. have outstanding?

Arteris, Inc. (AIP) had 45M shares outstanding as of fiscal year 2025.

What is Arteris, Inc.'s current ratio?

Arteris, Inc. (AIP) had a current ratio of 1.13 as of fiscal year 2025, which is considered adequate.

What is Arteris, Inc.'s debt-to-equity ratio?

Arteris, Inc. (AIP) had a debt-to-equity ratio of -8.86 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Arteris, Inc.'s return on assets (ROA)?

Arteris, Inc. (AIP) had a return on assets of -30.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Why is Arteris, Inc.'s debt-to-equity ratio negative or unusual?

Arteris, Inc. (AIP) has negative shareholder equity of -$14.6M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Arteris, Inc.'s Piotroski F-Score?

Arteris, Inc. (AIP) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Arteris, Inc.'s earnings high quality?

Arteris, Inc. (AIP) has an earnings quality ratio of -0.19x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Arteris, Inc. cover its interest payments?

Arteris, Inc. (AIP) has an interest coverage ratio of -171.7x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Arteris, Inc.?

Arteris, Inc. (AIP) scores 15 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.